Earnings Reportpositive

Earnings Report

Other upcoming events for LYEL

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Randomized Controlled Trial of Rondecabtagene Autoleucel , an Autologous, Dual-targeting C

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar